HLA-B27 Has Poor Diagnostic Utility for Polymyalgia Rheumatica
HLA-B27 testing is not useful for diagnosing polymyalgia rheumatica (PMR) and should not be routinely ordered. The test has low sensitivity (approximately 9%) and lacks specificity for this condition 1.
Key Diagnostic Performance Data
The available evidence demonstrates that HLA-B27 has minimal diagnostic value in PMR:
- Sensitivity: ~9.3% - Only a small minority of PMR patients test positive for HLA-B27 1
- Specificity: Not diagnostically useful - The frequency in PMR patients (9.3%) does not significantly differ from the general population (16.9%) 1
This contrasts sharply with conditions where HLA-B27 is clinically relevant, such as ankylosing spondylitis where positivity rates exceed 90%.
Clinical Implications and Diagnostic Approach
PMR diagnosis relies on clinical criteria, not HLA-B27 testing. The 2015 EULAR/ACR guidelines for PMR management make no mention of HLA-B27 testing in their diagnostic workup 2. Instead, diagnosis is based on:
- Age >50 years
- Bilateral shoulder pain with or without hip/neck involvement
- Pronounced morning stiffness
- Elevated inflammatory markers (ESR and CRP)
- Exclusion of other conditions including giant cell arteritis 3
Important Distinction from Spondyloarthropathies
A positive HLA-B27 in a patient with PMR-like symptoms should prompt reconsideration of the diagnosis. While rare case reports describe PMR occurring in HLA-B27-positive patients with ankylosing spondylitis 4, this represents an unusual overlap rather than typical PMR. HLA-B27 positivity is strongly associated with:
- Earlier disease onset (mean age 42-46 years vs. 49-55 years) 5, 6
- Axial skeletal involvement 5, 6
- Enthesitis 5
- Higher systemic inflammation 5, 6
These features are inconsistent with typical PMR, which affects older adults (>50 years) with proximal limb girdle symptoms rather than axial disease.
Common Pitfall to Avoid
Do not order HLA-B27 testing when PMR is suspected based on typical clinical features. The test will be negative in >90% of true PMR cases and provides no diagnostic value. If HLA-B27 returns positive in a patient with suspected PMR, consider alternative diagnoses within the spondyloarthritis spectrum, particularly if the patient has axial symptoms, enthesitis, or is younger than typical for PMR.